Project Grant HT94252510969
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Phoenix, AZ 85012, USA
Similar Awards
- This $1,844,306 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Michigan to cotarget the NSD1/2 paralogs in androgen receptor (AR)-driven castration-resistant prostate cancer. The research aims to transform healthcare for military service members, veterans, and the public by developing innovative medical solutions to address critical health challenges. The project will run...
- This $1,460,695 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" at The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. over the period of September 1, 2025 to August 31, 2028. The project aims to transform healthcare for military service members, veterans, and...
- This federal Project Grant award of $1,782,155 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The award, with a performance period from April 1,...
- This Project Grant award of $459,360.00 from the U.S. Defense Health Agency supports research on the "Genetic Risk of Prostate Cancer in Self-Identified Black Veterans" at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The research is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical investigations aimed at transforming healthcare for military service members, veterans, and...
- The federal Project Grant award for "IMPROVING DELIVERY OF GERMLINE TESTING IN VETERANS WITH ADVANCED PROSTATE CANCER" was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $3,051,639 grant was awarded to the Northern California Institute for Research and Education, Inc. (NCIRE) on September 1, 2025, with a project completion date of August 31, 2029. The grant supports advanced biomedical research aimed at...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...
- This federal Project Grant award of $481,056, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of California, Davis to investigate the role of the protein ARHGEF2 in promoting neural lineage plasticity and treatment resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the general public by advancing the...
- This Project Grant award from the U.S. Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,836,611.00 to Virginia Commonwealth University to fund a project titled "THERAPY OF ADVANCED PROSTATE CANCER WITH A NOVEL CELL THERAPY". The project aims to develop innovative medical solutions to address critical health challenges relevant to military personnel and civilian populations. The award has a performance period from September 1,...
- The University of Arizona was awarded a $1,791,407 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on March 1, 2025. The grant will fund research targeting drug resistance in the bone microenvironment using a novel PIM-PROTAC, with an ultimate completion date of February 29, 2028. This research initiative aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...